Literature DB >> 6897945

Inverse effects of dansylation of red blood cell membrane on band 3 protein-mediated transport of sulphate and chloride.

S Lepke, H Passow.   

Abstract

1. Dansylation of the red cell membrane produces inverse effects on SO(4) (2-) and Cl(-) equilibrium exchange. The former is enhanced by several orders of magnitude (Legrum, Fasold & Passow, 1980), the latter is inhibited. Both effects are potentiated after dansylation in the presence of 2-(4-amino-3-sulphophenyl)-6-methyl-7-benzothiazol sulphonic acid (APMB), a disulphonic acid that combines non-covalently with the 4,4'-diisothiocyanate dihydrostilbene-2,2'-disulphonic acid (H(2)DIDS) binding site of the anion transport protein.2. After dansylation the maximum of the pH dependence of SO(4) (2-) exchange near pH 6.3 is replaced by a plateau. When dansylation is performed in the presence of APMB, the plateau is reached at a much higher level at around pH 7.0 and resembles that observed by Funder & Wieth (1976) for Cl(-).3. The mutual interactions between the transfer site, the H(2)DIDS binding site, and the as yet unidentified danysl chloride binding sites were studied in detail. Occupation of the H(2)DIDS binding site by the non-covalently binding agents 4,4'-dinitrostilbene-2,2'-disulphonate (DNDS), 4,4'-bis(acetamido) stilbene-2,2'-disulphonate (DAS) or APMB inhibit the enhanced SO(4) (2-) exchange across the previously dansylated membrane. The apparent K(I) value remains the same as in untreated membranes for DNDS, is reduced to 1/3 for DAS, and to 1/60 for APMB. Conversely, when dansylation is carried out while the H(2)DIDS binding site is occupied by DNDS, APMB or DAS, the enhancement of SO(4) (2-) exchange (as measured after removal of excess dansyl chloride and the additional agent) is prevented by DNDS, augmented by APMB and not affected by DAS. This suggests that the agents stabilize different conformations of the H(2)DIDS binding site that are associated with different accessibilities of the dansyl chloride binding sites.4. The SO(4) (2-) equilibrium exchange as measured at a fixed Cl(-) concentration is enhanced when the Cl(-) concentration at which dansylation is carried out is increased, indicating allosteric interactions between anion binding and the exposure of the dansyl chloride binding sites.5. The enhanced K(+) efflux from dansylated red cells is independent of the described modifications of the dansylation reaction by APMB, DAS or DNDS, demonstrating that there exists no simple correlation between the changes of anion and cation movements that are induced by dansylation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897945      PMCID: PMC1225645          DOI: 10.1113/jphysiol.1982.sp014251

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  20 in total

1.  Proton fluxes associated with erythrocyte membrane anion exchange.

Authors:  M L Jennings
Journal:  J Membr Biol       Date:  1976-08-26       Impact factor: 1.843

2.  Kinetic characteristics of the sulfate self-exchange in human red blood cells and red blood cell ghosts.

Authors:  K F Schnell; S Gerhardt; A Schöppe-Fredenburg
Journal:  J Membr Biol       Date:  1977-01-28       Impact factor: 1.843

3.  Chloride transport in human red cells.

Authors:  M Dalmark
Journal:  J Physiol       Date:  1975-08       Impact factor: 5.182

4.  Transport of pyruvate nad lactate into human erythrocytes. Evidence for the involvement of the chloride carrier and a chloride-independent carrier.

Authors:  A P Halestrap
Journal:  Biochem J       Date:  1976-05-15       Impact factor: 3.857

Review 5.  Preparation and properties of human erythrocyte ghosts.

Authors:  G Schwoch; H Passow
Journal:  Mol Cell Biochem       Date:  1973-12-15       Impact factor: 3.396

6.  The reaction of 1-dimethylaminonaphthalene-5-sulfonyl chloride (DANSC1) with erythrocyte membranes. A new look at "vectorial" membrane probes.

Authors:  R Schmidt-Ullrich; H Knüfermann; D F Wallach
Journal:  Biochim Biophys Acta       Date:  1973-05-11

7.  Synthesis of tritiated 4,4'-diisothiocyano-2,2'-stilbene disulfonic acid ([3H]DIDS) and its covalent reaction with sites related to anion transport in human red blood cells.

Authors:  S Ship; Y Shami; W Breuer; A Rothstein
Journal:  J Membr Biol       Date:  1977-05-12       Impact factor: 1.843

8.  Chloride transport in human erythrocytes and ghosts: a quantitative comparison.

Authors:  J Funder; J O Wieth
Journal:  J Physiol       Date:  1976-11       Impact factor: 5.182

9.  A study of the relationship between inhibition of anion exchange and binding to the red blood cell membrane of 4,4'-diisothiocyano stilbene-2,2'-disulfonic acid (DIDS) and its dihydro derivative (H2DIDS).

Authors:  S Lepke; H Fasold; M Pring; H Passow
Journal:  J Membr Biol       Date:  1976-10-20       Impact factor: 1.843

10.  Characteristics of chloride transport in human red blood cells.

Authors:  R B Gunn; M Dalmark; D C Tosteson; J O Wieth
Journal:  J Gen Physiol       Date:  1973-02       Impact factor: 4.086

View more
  4 in total

1.  The absence of neuromuscular transmission failure in sustained maximal voluntary contractions.

Authors:  B Bigland-Ritchie; C G Kukulka; O C Lippold; J J Woods
Journal:  J Physiol       Date:  1982-09       Impact factor: 5.182

2.  Electrogenic sulfate/chloride exchange in Xenopus oocytes mediated by murine AE1 E699Q.

Authors:  M N Chernova; L Jiang; M Crest; M Hand; D H Vandorpe; K Strange; S L Alper
Journal:  J Gen Physiol       Date:  1997-03       Impact factor: 4.086

3.  Human placental sulphate transport: studies on chorionic trophoblast brush border membrane vesicles.

Authors:  C A Boyd; D B Shennan
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

4.  The kinetics of intramolecular cross-linking of the band 3 protein in the red blood cell membrane by 4,4'-diisothiocyano dihydrostilbene-2,2'-disulfonic acid (H2DIDS).

Authors:  L Kampmann; S Lepke; H Fasold; G Fritzsch; H Passow
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.